Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.arrowheadpharma.com
Arrowhead Pharmaceuticals Inc. News Releases
Get the latest updates from Arrowhead Pharmaceuticals Inc. News Releases directly as they happen.
Follow now 38 followers
Latest posts
Last updated 2 days ago
Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results
2 days ago
- Conference Call and Webcast Today, May 12, 2025 , at 4:30...
Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences
7 days ago
PASADENA, Calif. --(BUSINESS WIRE)--May 7, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today...
Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Second Quarter Results
14 days ago
PASADENA, Calif. --(BUSINESS WIRE)--Apr. 30, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today...
Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
29 days ago
PASADENA, Calif. --(BUSINESS WIRE)--Apr. 15, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today...
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
about 1 month ago
PASADENA, Calif. --(BUSINESS WIRE)--Apr. 4, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today...
Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy
2 months ago
- ARO-C3 achieved deep and sustained reductions in alternative pathway complement activity...
Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases
2 months ago
- ARO-INHBE and ARO-ALK7 both target a known pathway that signals the...
Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)
3 months ago
New Patient Resource Hub: Arrowhead expands its We’ll Get There Soon campaign...
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity
3 months ago
PASADENA, Calif. --(BUSINESS WIRE)--Feb. 25, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today...
Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results
3 months ago
- Conference Call and Webcast Today, February 10, 2025 , at 4:30...
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
3 months ago
PASADENA, Calif. --(BUSINESS WIRE)--Feb. 10, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today...
Arrowhead Pharmaceuticals to Webcast Fiscal 2025 First Quarter Results
4 months ago
PASADENA, Calif. --(BUSINESS WIRE)--Jan. 22, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today...